Reports

  • Assasi N, Blackhouse G, Campbell K, Hopkins R. Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients with suspected inflammatory disease or serious infection: a systematic review and economic analysis. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2015. pdf
  • Blackhouse G, Assasi N, Campbell K, Goeree R. Human fibrinogen concentrate (RiaSTAP):  Comparative cost-effectiveness evaluation. [CADTH Technology Report Issue 138, July 2014] Ottawa: Canadian Agency for Drugs and Technologies in Health; 2014. pdf
  • Masucci L, Blackhouse G, Goeree R. Cost-effectiveness of the carbon-13 urea breath test for the detection of helicobacter pylori: an economic analysis. Ontario Health Technology Assessment Series 2013;13(20):1-28. pdf
  • Chambers A, Bowen JM. Electrical stimuation for drug-resistant epilepsy: an evidence-based analysis. Ontario Health Technology Assessment Series 2013;13(18):1-37. pdf
  • Bowen JM, Whelan JP, Hopkins RB, Burke N, Woods EA, McIsaac GP, O'Reilly DJ, Xie F, Sehatzadeh S, Levin L, Mathew SP, Patterson LL, Goeree R, Tarride JE. Photoselective vaporization for the treatment of benign prostatic hyperplasia. Ontario Health Technology Assessment Series 2013;13(2):1-34. pdf
  • Degani N, Brener S, Chambers A, Franek J, Kaulback K, McMartin K, Nikitovic M, Levin L, Vanstone M, Giacomini M, DeJean D, Brundisini F, Winsor S, Smith A, Chandra K, Masucci L, Goeree R, Ieraci L, Chan B, Bermingham S, Krahn M. Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework. Ontario Health Technology Assessment Series 2013;13(3):1-78. pdf
  • Sehatzadeh S, Doble B, Xie F, Blackhouse G, Campbell K, Kaulback K, Chandra K, Goeree R. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update. Ontario Health Technology Assessment Series 2013;13(1):1-40. pdf
  • Assasi N, Blackhouse G, Campbell K, Hopkins R, Goeree R. High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation [science report] [CADTH Optimal Use Report, vol. 2 no. 1A]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013. pdf
  • Sehatzadeh S, Doble B, Xie F, Blackhouse G, Campbell K, Kaulback K, Chandra K, Goeree R. Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: An evidence-based analysis (Part B).  Ontario Health Technology Assessment Series 2012:12(14):1-62.pdf
  • Bowen JM, Snead OC, Chandra K, Blackhouse G, Goeree R. Epilepsy care in Ontario: an economic analysis of increasing access to epilepsy surgery. Ontario Health Technology Assessment Series 2012 July; 12(18):1-41. pdf
  1. 1
  2. 2
  3. 3
  4. 4
  5. Next page